- Home
- Products
TEYSUNO (Tegafur)
TEYSUNO (Tegafur)
- Medicine Name: TEYSUNO
- Generic Name: Tegafur, Gimeracil, and Oteracil
- Dosage Form & Strength: 20 mg / 5.8 mg / 15.8 mg (Capsules)
- Manufactured By: Taiho Pharmaceutical Co.
TEYSUNO is an oral chemotherapy drug used for the treatment of advanced gastric (stomach) cancer. It is a fixed-dose combination of three active ingredients:
- Tegafur: a prodrug of 5-fluorouracil (5-FU), which inhibits DNA synthesis
- Gimeracil: inhibits the degradation of 5-FU, enhancing its efficacy
- Oteracil: reduces gastrointestinal toxicity of 5-FU
TEYSUNO is commonly prescribed in combination with cisplatin for adult patients diagnosed with advanced or metastatic gastric cancer.
Patients with low white blood cell (WBC) counts must be monitored closely for infections or complications related to neutropenia.
Hepatitis B virus (HBV) testing is advised prior to initiating therapy.
In case of diarrhea, patients should be monitored for dehydration and receive appropriate fluid and electrolyte replacement therapy.
A DPD enzyme deficiency test is recommended before starting TEYSUNO, as DPD deficiency can increase the risk of severe toxicity.
To legally import TEYSUNO into India via Global Rare Meds, the following documents are required:
Required Documentation:
- A valid prescription from a certified oncologist
- Diagnostic test reports supporting the need for treatment
- Government-issued identity proof of the patient
- Import permit (if required)
Availability in India:
TEYSUNO is not commercially available in Indian pharmacies and must be imported on a named-patient basis. Global Rare Meds helps facilitate access in cities such as Mumbai, Delhi, Hyderabad, Chennai, Bengaluru, Kolkata, Ahmedabad, Pune, and more.
📧 Email: info@globalraremeds.com
📞 Call / WhatsApp: +91-99675 15602
Global Rare Meds sources TEYSUNO from certified global suppliers to ensure authenticity and timely delivery:
- Sourced from countries such as the USA, Canada, Europe, and Japan
- Dispensed under strict prescription validation
- Dispatched from our fulfillment center located in Ambernath, Thane District
- Secure and temperature-controlled logistics available for pan-India and international delivery
Q1: What is the generic name of Teysuno?
A: The generic name is Tegafur, Gimeracil, and Oteracil.
Q2: Who manufactures Teysuno?
A: TEYSUNO is manufactured by Taiho Pharmaceutical Co.
Q3: What form is Teysuno available in?
A: Teysuno is supplied as oral capsules, with each capsule containing Tegafur 20 mg, Gimeracil 5.8 mg, and Oteracil 15.8 mg.
Q4: What is the common treatment use for Teysuno?
A: Teysuno is used in combination with cisplatin for treating advanced gastric cancer.
Q5: What are the precautions before taking Teysuno?
A: Patients should be screened for DPD enzyme deficiency and HBV infection before initiating treatment.
Q6: Is Teysuno available in India?
A: TEYSUNO is not widely available in Indian pharmacies but can be legally imported with the help of Global Rare Meds.
Q7: What is the cost of Teysuno in India?
A: Prices may vary depending on international sourcing and strength. For a quotation, contact +91-99675 15602 or email info@globalraremeds.com
Q8: Is it safe to order Teysuno online from India?
A: Yes, Global Rare Meds offers a secure and compliant procurement process, ensuring delivery of authentic TEYSUNO to patients across India.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
